Product

Tyvaso

Aliases

Treprostinil, Tyvaso Inhalation Solution

Name

TYVASO

INN Name

treprostinil

FDA Approved

Yes

1 clinical trial

1 organization

1 indication

1 document

Indication

Pulmonary Arterial Hypertension

Clinical trial

An Evaluation of the Safety and Efficacy of the Addition of UT-15C SR to Pulmonary Arterial Hypertension Patients Currently Receiving Tyvaso®

Status: Completed, Estimated PCD: 2013-11-01

Document

DailyMed Label: TYVASO

Organization

United Therapeutics Corporation